Results 191 to 200 of about 857,514 (313)
An ex vivo glomerular filtration barrier is engineered using electrospun, biomimetic membranes seeded with human glomerular cells. The model supports fenestrated endothelium and podocyte foot processes under flow, mimics size‐selective filtration, and enables disease modeling with hiPSC‐derived podocytes, offering a powerful platform for studying ...
Camilla Mussoni+8 more
wiley +1 more source
Editorial: Cell cross-talk in diabetic kidney diseases, volume III. [PDF]
Wang R, Zhang L.
europepmc +1 more source
Extracellular vesicles (EVs) are pivotal mediators of intercellular communication and disease, yet the fundamental mechanisms controlling their biogenesis and cargo selection remain unclear. This limitation hinders their diagnostic utility and therapeutic development.
Luís Carvalho Ferraz+2 more
wiley +1 more source
Plasma proteome fingerprint in kidney diseases. [PDF]
Nikolsky KS+11 more
europepmc +1 more source
This study reports the development of bioinspired 2D crystalline Bionanozyme derived from a single nucleobase. It effectively mimics multienzyme activity to detect and remove phenolic pollutants, identify disease biomarkers with high sensitivity, and protect cells from oxidative stress.
Subrat Vishwakarma+8 more
wiley +1 more source
The microbial metabolite trimethylamine N-oxide and the kidney diseases. [PDF]
Su JQ+7 more
europepmc +1 more source
An Inquiry into the Nature and Pathology of Granular Disease of the Kidney, and its Mode of Action in Producing Albuminous Urine [PDF]
openalex +1 more source
GAMMA GLOBULIN AND COMPLEMENT IN THE DISEASED KIDNEY [PDF]
Paul D. Freedman, A. S. Markowitz
openalex +1 more source
Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs
This study demonstrates the safety of repeated application of three types of microarray patches (MAPs), hydrogelforming, dissolving, and implantable, over four weeks in miniature pigs. No adverse skin or systemic effects were observed, supporting the clinical potential of MAPs as safe and effective drug delivery platforms.
Qonita Kurnia Anjani+4 more
wiley +1 more source